Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Feldman

Showing results (171-180 of 1,291) with videos related to

Pageof 130
Sort By:
The Journal of Dermatological Treatment|April 12, 2023
Drug tolerability versus drug safetyStuti Prajapati, Rachel Tao, Steven R Feldman
The Journal of Dermatological Treatment|January 8, 2009
Equating topical treatment of severe psoriasis to keeping money in a mattressAli Alikhan, Neera Sodhi, Steven R Feldman
Cutis|January 14, 2016
A review of patient adherence to topical therapies for treatment of atopic dermatitisAlyson Snyder, Michael Farhangian, Steven R Feldman
Journal of the American Academy of Dermatology|May 18, 2016
Use of topical retinoids by dermatologists and non-dermatologists in the management of acne vulgarisSandra Pena, Dane Hill, Steven R Feldman
The Journal of Dermatological Treatment|May 18, 2016
Review of maintenance of response to psoriasis treatmentsSimona Bartos, Dane Hill, Steven R Feldman
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 12, 2016
Commentary on Cost of Actinic Keratoses and Skin CancersKerry M W Fike, Steven R Feldman
The American Journal of the Medical Sciences|May 14, 2018
Biosimilars for Immune-Mediated Chronic Diseases in Primary Care: What a Practicing Physician Needs to KnowSteven R Feldman, Jerry Bagel, Shahla Namak
American Journal of Clinical Dermatology|February 10, 2010
The role of tetracyclines in rosaceaAli Alikhan, Laura Kurek, Steven R Feldman
Patient Preference and Adherence|February 6, 2018
Barriers to treatment: describing them from a different perspectiveFrancesca Devine, Taylor Edwards, Steven R Feldman
Expert Review of Clinical Immunology|September 22, 2022
Treatment strategies, including antibiotics, to target the immune component of rosaceaKristen Delans, Katherine Kelly, Steven R Feldman
Pageof 130

Showing results (171-180 of 1,291) with videos related to

Sort By:
Pageof 130
The Journal of Dermatological Treatment|April 12, 2023
Drug tolerability versus drug safetyStuti Prajapati, Rachel Tao, Steven R Feldman
The Journal of Dermatological Treatment|January 8, 2009
Equating topical treatment of severe psoriasis to keeping money in a mattressAli Alikhan, Neera Sodhi, Steven R Feldman
Cutis|January 14, 2016
A review of patient adherence to topical therapies for treatment of atopic dermatitisAlyson Snyder, Michael Farhangian, Steven R Feldman
Journal of the American Academy of Dermatology|May 18, 2016
Use of topical retinoids by dermatologists and non-dermatologists in the management of acne vulgarisSandra Pena, Dane Hill, Steven R Feldman
The Journal of Dermatological Treatment|May 18, 2016
Review of maintenance of response to psoriasis treatmentsSimona Bartos, Dane Hill, Steven R Feldman
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 12, 2016
Commentary on Cost of Actinic Keratoses and Skin CancersKerry M W Fike, Steven R Feldman
The American Journal of the Medical Sciences|May 14, 2018
Biosimilars for Immune-Mediated Chronic Diseases in Primary Care: What a Practicing Physician Needs to KnowSteven R Feldman, Jerry Bagel, Shahla Namak
American Journal of Clinical Dermatology|February 10, 2010
The role of tetracyclines in rosaceaAli Alikhan, Laura Kurek, Steven R Feldman
Patient Preference and Adherence|February 6, 2018
Barriers to treatment: describing them from a different perspectiveFrancesca Devine, Taylor Edwards, Steven R Feldman
Expert Review of Clinical Immunology|September 22, 2022
Treatment strategies, including antibiotics, to target the immune component of rosaceaKristen Delans, Katherine Kelly, Steven R Feldman
Pageof 130